New Long-Acting pill could smooth Parkinson's symptoms
Disease control
Completed
This study tests an extended-release tablet containing carbidopa and levodopa (WD-1603) for people with early Parkinson's disease. The goal is to see if taking the medication three times daily improves motor symptoms and daily living better than a placebo. The trial involves 40 a…
Phase: PHASE2 • Sponsor: Shanghai WD Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC